East Timor dengue fatality down, DHF (dengue haemorrhagic fever) rates still high:
This article was originally published in Clinica
Executive Summary
More than 70% of the 178 hospitalised cases of dengue infection in East Timor had clinical features compatible with dengue haemorrhagic fever (DHF), the World Health Organization reported on February 10. The remainder were diagnosed as suspected dengue fever - ie the less virulent form of the disease - using WHO standard case definitions. The case fatality ratio has decreased since the beginning of the outbreak, but last stood at 9%, at 16 deaths.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
Novartis Hires Ex-BMS Chief As It Pursues US Growth Strategy
The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.
Maxwellia Delivers Two UK Menstrual Health Rx-To-OTC Switches
UK switch specialist Maxwellia delivers two “me too” reclassifications in the area of women's health: Evana Heavy Period Relief and Ultravana Period Pain Relief.